Answers are grounded in this paper and cite their sources.
Retinoic acid (RA) induces tumor cell differentiation in diseases like acute promyelocytic leukemia or high-risk neuroblastoma. However, the formation of resistant cells, which results from dysregulation of different signaling pathways, limits therapy success. The present study aimed to characterize basic regulatory processes induced by the application of RA in human neuroblastoma cells, to identify therapeutic targets independent of the often amplified oncogene MYCN.
No takes yet. Share an insight, caveat, or question.
Issa et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: